InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.04
(
0.14%
)
Bitcoin
57,357.24
(
-4.66%
)
Post# of 1367
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 863

Tuesday, 09/25/2007 5:15:33 AM

Tuesday, September 25, 2007 5:15:33 AM

Post# of 1367
Last time they spoke about their nucleoside CF102, was August 19, 2007. They said they completed the preclinical trials in collaboration with Temple University in Philadelphia which showed that CF102 is also active against the hepatitis virus. They want to start clinical trials by the end of the year.

I am going to meet with the company after the holidays, will add any more useful data provided at the presentation.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up